MedTrace Logo

Probiotic Therapy for Children and Adults With Autism Spectrum Disorder

NCT04655326 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 296

Last updated 2026-04-09

Study results available
· View outcomes & findings →

Summary

This is a study of the effect of a customized probiotic on children and adults with autism, including effects on autism symptoms and gastrointestinal symptoms.

Conditions

Interventions

DIETARY_SUPPLEMENT

Flore

personalized blend of GRAS approved probiotic strains, prebiotics, and botanicals

Sponsors & Collaborators

  • Sun Genomics

    collaborator UNKNOWN

  • Arizona State University

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Months
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-15
Primary Completion
2025-05-15
Completion
2025-07-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04655326 on ClinicalTrials.gov